AquaBounty (AQB): National Securities started coverage on...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	29
Posts	1293
Boards Moderated	0
Alias Born	01/04/2010

V1nc3

Re: buxmaker post# 172

Sunday, 03/10/2019 1:19:47 PM

Sunday, March 10, 2019 1:19:47 PM

National Securities started coverage on shares of Aquabounty Technologies (NASDAQ:AQB) in a report released on Wednesday, MarketBeat Ratings reports. The firm issued a buy rating and a $6.50 price target on the stock.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AQB News

Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 01:04:57 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 01:13:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 01:03:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 12:09:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 12:44:07 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/01/2023 10:08:56 AM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/01/2023 10:05:27 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/18/2023 09:14:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:07:19 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/04/2023 11:24:55 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2023 12:44:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 12:36:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 08:05:53 PM
AquaBounty Announces a Pause to Ohio Farm Construction While It Evaluates Scope Alternatives and a Possible Phased Approach • GlobeNewswire Inc. • 06/02/2023 12:00:00 PM

More AQB News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover